Q2B26 Copenhagen | Thomas Ehmer, Innovation Incubator Lead, Merck Healthcare

Q2B26 Copenhagen | Thomas Ehmer, Innovation Incubator Lead, Merck Healthcare

by Thomas Ehmer · View the channel on PSI

Humanities, Social Sciences & Thought Economics & Finance KJBusiness and ManagementKJDBusiness innovation
🎙 Thomas Ehmer 👥 6K 📅 October 12, 2026 ⏱ 20 min 👁 47 📄 expert opinion 🧭 2026-10-15
Available in: English (current) Français

Keywords

quantum computingquantum sensinghealthcarereservoir computinginnovation

Summary

Thomas Ehmer, Innovation Incubator Lead at Merck Healthcare, delivers a talk at Q2B26 Copenhagen about Merck’s approach to quantum technology. He starts by assessing the audience’s familiarity with quantum tech and outlines Merck’s structure, distinguishing itself from Merck & Co. He then gives a brief overview of quantum principles, including qubits and entanglement, and discusses the hype cycle, noting that investments have declined. Merck has been monitoring the field with a small team, participating in consortia like QUTAC, and investing selectively (e.g., in a company called Seek). He contrasts Merck’s strategy with larger players like Boehringer Ingelheim, emphasizing a broad network and federal-funded projects. He identifies near-term opportunities in quantum sensing and mentions the need for many logical qubits for molecular simulation (80,000), which he avoids by working on quantum reservoir computing for rare disease data and MRI time-series classification. The talk also covers potential business models, including becoming a provider via electronics and isotope businesses, and asks the community for feedback on the idea of modeling the ‘whole person’ as a quantum state. He concludes with questions about post-quantum cryptography and quantum communication.

184 words

Critical Evaluation

Value of the Information & Strength of the Argument

The value of the talk lies in its practical, business-oriented perspective on quantum technology, sharing Merck’s actual journey through the hype cycle, including investments and collaborations. The argumentation is built on personal experience and limited data, such as the number of quantum companies and anecdotal successes (e.g., Seek IPO). While the speaker is transparent about uncertainties and invites feedback, the reasoning is not deeply rigorous—claims about ’less bad’ results in reservoir computing are mentioned without data, and the ‘whole person as a quantum state’ concept is speculative. The strength of the argument is moderate, as it focuses on strategic considerations rather than technical proofs.

Scientific Rigor, Source Quality, Title Accuracy

The talk lacks explicit citations or references to external studies; the only provided link is to the Q2B conference website. The speaker mentions collaborations (e.g., University of Bonn) and papers but does not name them. This weakens the scientific rigor. The title is purely informational (event and speaker) and does not reflect the content, which is about quantum technology in healthcare and business strategy. The adequacy between title and content is low, but this is a minor issue as it’s a conference presentation.

202 words

Title / Content Match

The title simply names the event and speaker, giving no indication of the content; the talk covers quantum technology adoption in healthcare and business strategy.

Quality & Reliability

6/10

The talk offers a business perspective on quantum technology with some data points (company counts, investment trends) but relies heavily on personal experience and anecdotal evidence. No specific sources or data citations are given, and the speaker acknowledges uncertainty on outcomes.

Key Moments

Markers derived by PSI from the transcript: the creator did not define chapters.

Cited Sources

Concurring Sources

  • Q2B Conference Website — As the venue, it likely lists related talks and materials that align with the content presented.

Contribution & Novelties

The talk provides a unique insider view of how a large healthcare/materials company navigates the quantum landscape, proposing a speculative ‘quantum state of the whole person’ and advocating for quantum reservoir computing in data-sparse healthcare scenarios. It challenges the dominant focus on drug discovery and suggests sensing and computing as near-term opportunities.

Pour aller plus loin :

  • Quantum computing — Overview of quantum computing fundamentals relevant to the talk’s core topic.
  • Quantum sensing — Discussion of quantum sensing technologies mentioned as near-term opportunities.
  • Post-quantum cryptography — Relevant to the Q&A on protecting data against quantum attacks.

96 words

Radar Profile

The radar profile shows moderate scores across all dimensions, with qualitative information and reliability slightly above quantity and technicality. This indicates a talk that offers some insights but lacks depth and rigor, consistent with an expert opinion rather than a rigorous scientific presentation.

Reliability 6/10